APOL1 Nephropathy Risk Variants and Incident Cardiovascular Disease Events in Community-Dwelling Black Adults

被引:27
|
作者
Gutierrez, Orlando M. [1 ]
Irvin, Marguerite R. [2 ]
Chaudhary, Ninad S. [2 ]
Cushman, Mary [4 ]
Zakai, Neil A. [4 ]
David, Victor A. [5 ]
Limou, Sophie [6 ,7 ]
Pamir, Nathalie [8 ]
Reiner, Alex P. [9 ]
Naik, Rakhi P. [10 ]
Sale, Michele M. [11 ]
Safford, Monika M. [12 ]
Hyacinth, Hyacinth, I [13 ]
Judd, Suzanne E. [3 ]
Kopp, Jeffrey B. [14 ]
Winkler, Cheryl A. [6 ]
机构
[1] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA
[3] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA
[4] Univ Vermont, Div Hematol & Oncol, Burlington, VT USA
[5] NCI, Basic Res Lab, Ctr Canc Res, Frederick, MD 21701 USA
[6] NCI, Basic Res Lab, NIH, Leidos Biomed Res,Frederick Natl Lab, Frederick, MD 21701 USA
[7] Univ Nantes, Ctr Res Immunol & Transplantat, Nantes, France
[8] Oregon Hlth & Sci Univ, Knight Cardiovasc Inst, Portland, OR 97201 USA
[9] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA
[10] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
[11] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA USA
[12] Weill Cornell Med, Div Gen Internal Med, New York, NY USA
[13] Emory Univ, Dept Pediat, Aflac Canc & Blood Disorder Ctr, Childrens Healthcare Atlanta, Atlanta, GA 30322 USA
[14] NIDDK, Kidney Dis Branch, NIH, Bethesda, MD 20892 USA
来源
基金
美国国家卫生研究院;
关键词
cardiac catheterization; cardiovascular diseases; genetics; myocardial infarction; stroke; GLOMERULAR-FILTRATION-RATE; DENSITY-LIPOPROTEIN CHOLESTEROL; ISCHEMIC-STROKE SUBTYPES; SYSTOLIC BLOOD-PRESSURE; CORONARY-HEART-DISEASE; KIDNEY-DISEASE; RACIAL-DIFFERENCES; AFRICAN-AMERICANS; ALL-CAUSE; COLLABORATIVE METAANALYSIS;
D O I
10.1161/CIRCGEN.117.002098
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: APOL1 renal risk variants are strongly associated with chronic kidney disease in Black adults, but reported associations with cardiovascular disease (CVD) have been conflicting. METHODS: We examined associations of APOL1 with incident coronary heart disease (n=323), ischemic stroke (n=331), and the composite CVD outcome (n=500) in 10 605 Black participants of the REGARDS study (Reasons for Geographic and Racial Differences in Stroke). Primary analyses compared individuals with APOL1 high-risk genotypes to APOL1 low-risk genotypes in Cox proportional hazards models adjusted for CVD risk factors and African ancestry. RESULTS: APOL1 high-risk participants were younger and more likely to have albuminuria at baseline than APOL1 low-risk participants. The risk of incident stroke, coronary heart disease, or composite CVD end point did not significantly differ by APOL1 genotype status in multivariable models. The association of APOL1 genotype with incident composite CVD differed by diabetes mellitus status (P-interaction=0.004). In those without diabetes mellitus, APOL1 high-risk genotypes associated with greater risk of incident composite CVD (hazard ratio, 1.67; 95% confidence interval, 1.12-2.47) compared with those with APOL1 low-risk genotypes in multivariable adjusted models. This latter association was driven by ischemic strokes (hazard ratio, 2.32; 95% confidence interval, 1.33-4.07), in particular, those related to small vessel disease (hazard ratio, 5.10; 95% confidence interval, 1.55-16.56). There was no statistically significant association of APOL1 genotypes with incident CVD in subjects with diabetes mellitus. The APOL1 high-risk genotype was associated with higher stroke risk in individuals without but not those with chronic kidney disease in fully adjusted models. CONCLUSIONS: APOL1 high-risk status is associated with CVD events in community-dwelling Black adults without diabetes mellitus.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] APOL1 risk variants drive kidney disease in mice
    Susan J. Allison
    Nature Reviews Nephrology, 2017, 13 : 259 - 259
  • [22] Increased Burden of Cardiovascular Disease in Carriers of APOL1 Genetic Variants
    Ito, Kaoru
    Bick, Alexander G.
    Flannick, Jason
    Friedman, David J.
    Genovese, Giulio
    Parfenov, Michael G.
    DePalma, Steven R.
    Gupta, Namrata
    Gabriel, Stacey B.
    Taylor, Herman A.
    Fox, Ervin R.
    Newton-Cheh, Christopher
    Kathiresan, Sekar
    Hirschhorn, Joel N.
    Altshuler, David M.
    Pollak, Martin R.
    Wilson, James G.
    Seidman, J. G.
    Seidman, Christine
    CIRCULATION RESEARCH, 2014, 114 (05) : 845 - 850
  • [23] Genome-Wide Evaluation of Epistasis with APOL1 Risk Variants in Sickle Cell Disease Nephropathy
    Garrett, Melanie E.
    Soldano, Karen L.
    Anderson, Blair R.
    Telen, Marilyn J.
    Ashley-Koch, Allison E.
    BLOOD, 2015, 126 (23)
  • [24] APOL1 Renal-Risk Variants Do Not Associate With Incident Cardiovascular Disease or Mortality in the Systolic Blood Pressure Intervention Trial
    Freedman, Barry I.
    Rocco, Michael V.
    Bates, Jeffrey T.
    Chonchol, Michel
    Hawfield, Amret T.
    Lash, James P.
    Papademetriou, Vasilios
    Sedor, John R.
    Servilla, Karen
    Kimmel, Paul L.
    Wall, Barry M.
    Pajewski, Nicholas M.
    KIDNEY INTERNATIONAL REPORTS, 2017, 2 (04): : 713 - 720
  • [25] APOL1 gene variants and kidney disease in whites: the cardiovascular health study
    Drury, Erika R.
    Friedman, David J.
    Pollak, Martin R.
    Ix, Joachim H.
    Kuller, Lewis H.
    Tracy, Russell P.
    Mukamal, Kenneth J.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 (12) : 2155 - 2156
  • [26] APOL1 Renal Risk Variants: Fertile Soil for HIV-Associated Nephropathy
    Kopp, Jeffrey B.
    Heymann, Jurgen
    Winkler, Cheryl A.
    SEMINARS IN NEPHROLOGY, 2017, 37 (06) : 514 - 519
  • [27] APOL1 Genotype, Kidney and Cardiovascular Disease, and Death in Older Adults
    Mukamal, Kenneth J.
    Tremaglio, Joseph
    Friedman, David J.
    Ix, Joachim H.
    Kuller, Lewis H.
    Tracy, Russell P.
    Pollak, Martin R.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2016, 36 (02) : 398 - 403
  • [28] APOL1 Risk Variants, Race, and Progression of Chronic Kidney Disease
    Parsa, Afshin
    Kao, W. H. Linda
    Xie, Dawei
    Astor, Brad C.
    Li, Man
    Hsu, Chi-yuan
    Feldman, Harold I.
    Parekh, Rulan S.
    Kusek, John W.
    Greene, Tom H.
    Fink, Jeffrey C.
    Anderson, Amanda H.
    Choi, Michael J.
    Wright, Jackson T., Jr.
    Lash, James P.
    Freedman, Barry I.
    Ojo, Akinlolu
    Winkler, Cheryl A.
    Raj, Dominic S.
    Kopp, Jeffrey B.
    He, Jiang
    Jensvold, Nancy G.
    Tao, Kaixiang
    Lipkowitz, Michael S.
    Appel, Lawrence J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (23): : 2183 - 2196
  • [29] The Expanding Role of APOL1 Risk in Chronic Kidney Disease and Cardiovascular Disease
    Estrella, Michelle M.
    Parekh, Rulan S.
    SEMINARS IN NEPHROLOGY, 2017, 37 (06) : 520 - 529
  • [30] Vascular Risk Factors, Cardiovascular Disease and Functional Impairment in Community-Dwelling Adults
    Canavan, Michelle
    Glynn, Liam G.
    Smyth, Andrew
    Mulkerrin, Eamon C.
    Murphy, Andrew W.
    Mulqueen, Joan
    McGrath, Emer R.
    O'Donnell, Martin J.
    GERONTOLOGY, 2014, 60 (03) : 212 - 221